Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines
Daily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for H...
Main Authors: | Edwina Wright, Andrew Grulich, Katy Roy, Mark Boyd, Vincent Cornelisse, Darren Russell, Darryl O'Donnell, Bill Whittaker, Levinia Crooks, Iryna Zablotska |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-07-01
|
Series: | Journal of Virus Eradication |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020303381 |
Similar Items
-
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018
by: Edwina Wright, et al.
Published: (2018-07-01) -
Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study
by: Kathleen E. Ryan, et al.
Published: (2018-05-01) -
Modeling HIV Pre-Exposure Prophylaxis
by: Thomas Straubinger, et al.
Published: (2020-01-01) -
Portuguese health care providers’ knowledge, attitudes, and acceptability of HIV pre-exposure prophylaxis
by: Rui Baptista-Gonçalves, et al.
Published: (2018-11-01) -
Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
by: Max von Kleist, et al.
Published: (2020-08-01)